The history of Viagra and its originator, copyright, presents a fascinating picture for potential investors. While the iconic drug initially generated enormous profits , its patent has ended, leading to rival options flooding the arena. This decline in cost presents a substantial obstacle for copyright and any company considering a heavy holding in